How they treat trans children across the pond
England's National Health Service made the major announcement last week that they would limit the prescription of puberty-blocking drugs for transgender children to clinical trials. A report released by the NHS on June 9 states that "there is not enough evidence to support their safety or clinical effectiveness as a routinely available treatment and that they should only be accessed as part of research." The decision is the latest consequence of a multi-year review into how the medical community in England should treat children who suffer from gender dysphoria.